Argan reported record second-quarter fiscal 2027 results for the three months ended July 31, 2026, with revenue up 61.5% year over year to $384.0 million and net income of $53.3 million, or $3.76 per diluted share, versus $2.50 a year earlier. Project backlog fell to about $2.5 billion from $2.9 billion at January 31, 2026, and the company reported no debt, which may matter to shareholders assessing future revenue visibility.
Q2 revenue rose $146.2 million to $384.0 million; gross margin was 19.3% versus 18.6% a year earlier
Diluted EPS was $3.76 versus $2.50; quarterly cash dividend per share was $0.500 versus $0.375
Project backlog was about $2.5 billion at July 31, 2026, down from $2.9 billion at January 31, 2026
Cash, cash equivalents and investments totaled $1.03 billion, and the company reported no debt
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Argan, Inc.'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2026
$944.61M
+8.1%
$9.74
+58.4%
14.6%
FY2025
$874.18M
+52.5%
$6.15
+157.3%
9.8%
FY2024
$573.33M
+26.0%
$2.39
+2.6%
5.6%
FY2023
$455.04M
-10.7%
$2.33
-2.9%
7.3%
FY2022
$509.37M
+29.9%
$2.40
+58.9%
7.5%
Frequently asked questions
When is Argan's next earnings date?
Argan has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Argan earn last quarter?
For the quarter ended Jul 2026, Argan reported diluted EPS of $3.76 (+50.4% year over year) on revenue of $383.98M (+61.5%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.